156 related articles for article (PubMed ID: 17179945)
1. Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris.
Woodward DF; Krauss AH; Wang JW; Protzman CE; Nieves AL; Liang Y; Donde Y; Burk RM; Landsverk K; Struble C
Br J Pharmacol; 2007 Feb; 150(3):342-52. PubMed ID: 17179945
[TBL] [Abstract][Full Text] [Related]
2. Prostamides (prostaglandin-ethanolamides) and their pharmacology.
Woodward DF; Liang Y; Krauss AH
Br J Pharmacol; 2008 Feb; 153(3):410-9. PubMed ID: 17721551
[TBL] [Abstract][Full Text] [Related]
3. Bimatoprost, prostamide activity, and conventional drainage.
Wan Z; Woodward DF; Cornell CL; Fliri HG; Martos JL; Pettit SN; Wang JW; Kharlamb AB; Wheeler LA; Garst ME; Landsverk KJ; Struble CS; Stamer WD
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4107-15. PubMed ID: 17724194
[TBL] [Abstract][Full Text] [Related]
4. Comparison of prostaglandin F2alpha, bimatoprost (prostamide), and butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression.
Liang Y; Li C; Guzman VM; Evinger AJ; Protzman CE; Krauss AH; Woodward DF
J Biol Chem; 2003 Jul; 278(29):27267-77. PubMed ID: 12724323
[TBL] [Abstract][Full Text] [Related]
5. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
Bhattacherjee P; Williams BS; Paterson CA
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
7. The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products.
Woodward DF; Carling RW; Cornell CL; Fliri HG; Martos JL; Pettit SN; Liang Y; Wang JW
Pharmacol Ther; 2008 Oct; 120(1):71-80. PubMed ID: 18700152
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in prostaglandin F2α ethanolamide (prostamide F2α) research and therapeutics.
Woodward DF; Wang JW; Poloso NJ
Pharmacol Rev; 2013; 65(4):1135-47. PubMed ID: 23893067
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin ethanolamides attenuate damage in a human explant colitis model.
Nicotra LL; Vu M; Harvey BS; Smid SD
Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():22-9. PubMed ID: 23380599
[TBL] [Abstract][Full Text] [Related]
10. Prostamide F(2) α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibition.
Ligresti A; Martos J; Wang J; Guida F; Allarà M; Palmieri V; Luongo L; Woodward D; Di Marzo V
Br J Pharmacol; 2014 Mar; 171(6):1408-19. PubMed ID: 24102214
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism.
Matias I; Chen J; De Petrocellis L; Bisogno T; Ligresti A; Fezza F; Krauss AH; Shi L; Protzman CE; Li C; Liang Y; Nieves AL; Kedzie KM; Burk RM; Di Marzo V; Woodward DF
J Pharmacol Exp Ther; 2004 May; 309(2):745-57. PubMed ID: 14757851
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2-Glyceryl Ester: In Vivo Evidence for a Distinct Pharmacological Identity from Intraocular Pressure Studies.
Woodward DF; Poloso NJ; Wang JW
J Pharmacol Exp Ther; 2016 Aug; 358(2):173-80. PubMed ID: 27217589
[TBL] [Abstract][Full Text] [Related]
13. Bimatoprost and prostaglandin F(2 alpha) selectively stimulate intracellular calcium signaling in different cat iris sphincter cells.
Spada CS; Krauss AH; Woodward DF; Chen J; Protzman CE; Nieves AL; Wheeler LA; Scott DF; Sachs G
Exp Eye Res; 2005 Jan; 80(1):135-45. PubMed ID: 15652534
[TBL] [Abstract][Full Text] [Related]
14. In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti-inflammatory effects.
Woodward DF; Wang JW; Ni M; Bauer A; Martos JL; Carling RW; Poloso NJ
FASEB J; 2017 Jan; 31(1):368-375. PubMed ID: 27770021
[TBL] [Abstract][Full Text] [Related]
15. Effects of prostaglandin F2alpha, latanoprost and carbachol on phosphoinositide turnover, MAP kinases, myosin light chain phosphorylation and contraction and functional existence and expression of FP receptors in bovine iris sphincter.
Ansari HR; Kaddour-Djebbar I; Abdel-Latif AA
Exp Eye Res; 2004 Feb; 78(2):285-96. PubMed ID: 14729360
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024).
Woodward DF; Krauss AH; Chen J; Liang Y; Li C; Protzman CE; Bogardus A; Chen R; Kedzie KM; Krauss HA; Gil DW; Kharlamb A; Wheeler LA; Babusis D; Welty D; Tang-Liu DD; Cherukury M; Andrews SW; Burk RM; Garst ME
J Pharmacol Exp Ther; 2003 May; 305(2):772-85. PubMed ID: 12606640
[TBL] [Abstract][Full Text] [Related]
17. AL-3138 antagonizes FP prostanoid receptor-mediated inositol phosphates generation: comparison with some purported FP antagonists.
Sharif NA; Crider JY; Davis TL
J Pharm Pharmacol; 2000 Dec; 52(12):1529-39. PubMed ID: 11197083
[TBL] [Abstract][Full Text] [Related]
18. Cat iris sphincter smooth-muscle contraction: comparison of FP-class prostaglandin analog agonist activities.
Sharif NA; Kaddour-Djebbar I; Abdel-Latif AA
J Ocul Pharmacol Ther; 2008 Apr; 24(2):152-63. PubMed ID: 18355130
[TBL] [Abstract][Full Text] [Related]
19. Prostanoid receptors mediating contraction in rat, macaque and human bladder smooth muscle in vitro.
Root JA; Davey DA; Af Forselles KJ
Eur J Pharmacol; 2015 Dec; 769():274-9. PubMed ID: 26607459
[TBL] [Abstract][Full Text] [Related]
20. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
